PROACT PLUS Registry and Echo Sub-study: Can we detect early chemotherapy-related heart damage?
Not Applicable
Completed
- Conditions
- Breast cancerCancerMalignant neoplasm of breast
- Registration Number
- ISRCTN11676341
- Lead Sponsor
- South Tees NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
1. Adult patients with a new diagnosis of histopathologically confirmed breast carcinoma
2. Age = 18
3. Planned to receive anthracycline based treatment (adjuvant or neoadjuvant) – any dose
4. Written informed consent
Exclusion Criteria
1. Meets eligibility criteria for the PROACT trial*
2. Known metastatic breast cancer
*Patients who are otherwise eligible for the PROACT trial will not be eligible to participate in the PROACT registry
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method